IBDEI0HM ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8216,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,8216,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,8216,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,8217,0)
 ;;=V10.05^^35^482^59
 ;;^UTILITY(U,$J,358.3,8217,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8217,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,8217,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,8217,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,8218,0)
 ;;=V10.03^^35^482^60
 ;;^UTILITY(U,$J,358.3,8218,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8218,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,8218,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,8218,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,8219,0)
 ;;=V10.60^^35^482^62
 ;;^UTILITY(U,$J,358.3,8219,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8219,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,8219,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,8219,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,8220,0)
 ;;=V10.11^^35^482^63
 ;;^UTILITY(U,$J,358.3,8220,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8220,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,8220,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,8220,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,8221,0)
 ;;=V10.79^^35^482^64
 ;;^UTILITY(U,$J,358.3,8221,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8221,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,8221,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,8221,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,8222,0)
 ;;=V10.82^^35^482^65
 ;;^UTILITY(U,$J,358.3,8222,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8222,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,8222,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,8222,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,8223,0)
 ;;=V10.02^^35^482^68
 ;;^UTILITY(U,$J,358.3,8223,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8223,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,8223,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,8223,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,8224,0)
 ;;=V10.43^^35^482^69
 ;;^UTILITY(U,$J,358.3,8224,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8224,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,8224,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,8224,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,8225,0)
 ;;=V10.46^^35^482^70
 ;;^UTILITY(U,$J,358.3,8225,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8225,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,8225,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,8225,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,8226,0)
 ;;=V10.06^^35^482^71
 ;;^UTILITY(U,$J,358.3,8226,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8226,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,8226,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,8226,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,8227,0)
 ;;=V10.52^^35^482^72
 ;;^UTILITY(U,$J,358.3,8227,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8227,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,8227,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,8227,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,8228,0)
 ;;=V10.04^^35^482^74
 ;;^UTILITY(U,$J,358.3,8228,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8228,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,8228,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,8228,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,8229,0)
 ;;=V10.47^^35^482^75
 ;;^UTILITY(U,$J,358.3,8229,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8229,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,8229,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,8229,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,8230,0)
 ;;=V10.83^^35^482^73
 ;;
 ;;$END ROU IBDEI0HM
